Search

Oral Flat Panel Detector Market Size to Reach USD 560 Million by 2032 | Dental Imaging Trends Global oral flat panel detector market is witnessing steady expansion as digital dentistry becomes a core component of modern oral healthcare. Valued at approximately USD 320 million in 2024, the market is expected to grow from USD 345 million in 2025 to USD 560 million by 2032, registering a compound annual growth rate (CAGR) of around 7.2% during the forecast period. This growth is driven by the rapid replacement of analog imaging systems, rising demand for high-resolution diagnostics, and increasing adoption of advanced dental technologies across clinical settings. Access the complete report https://www.24lifesciences.com/oral-flat-panel-detector-market-9920

Facial Paralysis Treatment Market Size to Reach USD 3.4 Billion by 2032 | Growth Forecasts & Insights Global facial paralysis treatment market is witnessing strong momentum as healthcare systems increasingly prioritize neurological rehabilitation, early intervention, and functional recovery. Valued at USD 1.8 billion in 2024, the market is expected to expand from USD 1.95 billion in 2025 to USD 3.4 billion by 2032, registering a robust CAGR of 7.2% during the forecast period. This growth reflects rising disease awareness, advances in medical therapies and surgical techniques, and growing demand for comprehensive, multidisciplinary care models. Access the complete report https://www.24lifesciences.com/facial-paralysis-treatment-market-9209

Circulating Tumor Cell Detector Market Size to Reach USD 15.1 Billion by 2032 | Growth Insights Global circulating tumor cell detector market is undergoing a pivotal transformation as oncology care shifts toward non-invasive, precision-driven diagnostics. Valued at USD 7.2 billion in 2024, the market is projected to grow from USD 7.9 billion in 2025 to USD 15.1 billion by 2032, expanding at a CAGR of 9.4% during the forecast period. This sustained growth reflects the rising global cancer burden and the increasing clinical reliance on liquid biopsy technologies to guide diagnosis, prognosis, and treatment monitoring. Access the complete report https://www.24lifesciences.com/circulating-tumor-cell-detector-market-10059

Multiple Sclerosis Treatment Market Size to Reach USD 19.1 Billion by 2032 | Growth Global multiple sclerosis treatment market is undergoing steady clinical and commercial evolution as healthcare systems prioritize early diagnosis, disease modification, and long-term neurological care. Valued at USD 16.5 billion in 2024, the market is projected to grow from USD 16.9 billion in 2025 to USD 19.1 billion by 2032, registering a CAGR of 2.2% over the forecast period. This measured growth reflects the maturity of established therapies alongside continuous innovation in high-efficacy disease-modifying treatments (DMTs). Access the complete report https://www.24lifesciences.com/multiple-sclerosis-treatment-market-9542

Tortilla Market Expected to Reach $80.03 Billion by 2035 The global tortilla market is on a growth trajectory, with the market size reaching USD 47.75 billion in 2025. It is projected to rise from USD 50.28 billion in 2026 to approximately USD 80.03 billion by 2035, registering a CAGR of 5.3% during the forecast period from 2026 to 2035. This growth is largely driven by the rising consumer demand for ready-to-eat and convenient food products, as tortillas increasingly feature in everyday diets worldwide. The market expansion reflects shifting lifestyles, urbanization, and the growing preference for quick, versatile, and nutritious meal options. Industry stakeholders are expected to leverage this growth by innovating with flavored, whole grain, and specialty tortillas to cater to evolving consumer tastes and preferences.

Acai Berry Market Set to Reach $3.28 Billion by 2035 The global acai berry market is witnessing steady growth, with the market size estimated at USD 1.65 billion in 2025. It is projected to expand to USD 1.77 billion in 2026 and reach nearly USD 3.28 billion by 2035, registering a CAGR of 7.1% during the forecast period from 2026 to 2035. The growth is driven primarily by the rising popularity of acai berries as a superfood, alongside increasing consumer demand for dietary supplements and cosmetic products enriched with natural antioxidants. The market’s expansion reflects a broader trend toward health-conscious lifestyles and natural product adoption globally. As acai continues to gain traction in functional foods, beverages, and personal care products, industry players are expected to capitalize on this lucrative growth opportunity in both emerging and established markets.

Peptide and Heparin Market Size to Reach USD 58.9 Billion by 2031 | Growth Insights Global peptide and heparin market is undergoing steady and strategic expansion, supported by rising demand for advanced biologic therapies and critical anticoagulation treatments. Valued at USD 42.5 billion in 2024, the market is projected to reach USD 58.9 billion by 2031, growing at a CAGR of 4.8% during the forecast period. This growth reflects the increasing clinical reliance on peptide-based drugs and heparin across cardiovascular care, oncology, and metabolic disorder management worldwide. Access the complete report https://www.24lifesciences.com/peptide-and-heparin-market-9010

Predictive Genetic Testing and Consumer & Wellness Genomics Market Size to Reach USD 10.23 Billion by 2032 Global Predictive Genetic Testing and Consumer & Wellness Genomics Market is undergoing a period of rapid expansion as healthcare systems and individuals increasingly embrace preventive, data-driven health strategies. Valued at USD 3.51 billion in 2024, the market is projected to grow from USD 4.05 billion in 2025 to USD 10.23 billion by 2032, registering a robust CAGR of 14.1% during the forecast period. This growth reflects rising demand for personalized healthcare, early disease risk assessment, and wellness optimization powered by genomic insights. Access the market report https://www.24lifesciences.com/predictive-genetic-testing-and-consumer-wellness-genomics-market-9425

Ultrasound Endoscope Market Size to Reach USD 3.6 Billion by 2032 | Growth Trends & Insights Global ultrasound endoscope market is witnessing steady and technology-driven growth as healthcare systems increasingly prioritize minimally invasive diagnostics and precision-guided interventions. Valued at USD 2.3 billion in 2024, the market is projected to reach USD 3.6 billion by 2032, expanding at a CAGR of 5.8% during the forecast period. This upward trajectory reflects rising procedural volumes, expanding clinical applications, and continuous innovation in endoscopic imaging technologies across both developed and emerging healthcare markets. Ultrasound endoscopes have become indispensable tools in modern medicine, enabling clinicians to combine endoscopic visualization with high-resolution ultrasound imaging to improve diagnostic accuracy and therapeutic outcomes. Access the market report https://www.24lifesciences.com/ultrasound-endoscope-market-9926

Neuropsychiatric Disorders and Treatment Market Size to Reach USD 211.8 Billion by 2032 Global neuropsychiatric disorders and treatment market is entering a critical phase of expansion as mental health emerges as a central priority for healthcare systems worldwide. Valued at USD 146.5 billion in 2024, the market is projected to grow from USD 153.9 billion in 2025 to USD 211.8 billion by 2032, registering a CAGR of 4.9% over the forecast period. This sustained growth reflects rising diagnosis rates, increasing awareness, and steady innovation across pharmacological and non-pharmacological treatment pathways addressing complex neurological and psychiatric conditions. As societies confront the clinical, economic, and social burden of mental health disorders, neuropsychiatric care is increasingly viewed as a long-term healthcare investment rather than episodic intervention. Access the market report https://www.24lifesciences.com/neuropsychiatric-disorders-and-treatment-market-9553